Key Statistics
Market Cap$995.75M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.47
52W High$14.93
52W Low$3.90
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees104
Price Performance
1 Week-26.29%
3 Month+9.08%
1 Year+69.01%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$252.01M
Liabilities$27.92M
Net Income$100.70M loss
About
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ORIC with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.